This information was published on 2025-10-15T00:10:43 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2553980 (IR 1726566) |
| (220) |
14 May 2025
|
| (511) (510) |
Class 5
Monoclonal antibodies for medical purposes; antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprised of apitegromab; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders. |
| (540) | ISEMBYLD |
| (550) | Word |
| (730) |
Scholar Rock, Inc.
|
Find out more about publications on the About page.